Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia

American Journal of Respiratory Cell and Molecular Biology

Volumn 38, Issue 6, 2008, Pages 699-706

  Quinton, Lee J ^a   Jones, Matthew R ^a   Robson, Bryanne E ^a   Simms, Benjamin T ^a   Whitsett, Jeffrey A ^b   Mizgerd, Joseph P ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cytokines; Lung; Neutrophils; Pneumonia; STAT3

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTEROBACTER INFECTION; EPITHELIUM CELL; ESCHERICHIA COLI; GENE; GENE MUTATION; GENOTYPE; HOST RESISTANCE; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SERODIAGNOSIS; STAT3 GENE;

ANIMALS; CELL LINE; CHEMOKINES; CYTOKINES; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PNEUMONIA, BACTERIAL; PULMONARY ALVEOLI; STAT3 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE; MUS; NEGIBACTERIA;

EID: 45249090373     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0365OC     Document Type: Article

References (56)

1. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, et al. Future research directions in acute lung injury: summary of a national heart, lung, and blood institute working group. Am J Respir Crit Care Med 2003;167:1027-1035.
2. Mizgerd JP. Lung infection-a public health priority. PLoS Med 2006;3:e76.
3. Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J, Sanchez M, Martinez JA. Severe community-acquired pneumonia: risk factors and follow-up epidemiology. Am J Respir Crit Care Med 1999;160:923-929.
4. Ahmed QA, Niederman MS. Respiratory infection in the chronically critically ill patient. Ventilator-associated pneumonia and tracheobronchitis. Clin Chest Med 2001;22:71-85.
5. Mehrad B, Standiford TJ. Role of cytokines in pulmonary antimicrobial host defense. Immunol Res 1999;20:15-27.
6. Panopoulos AD, Zhang L, Snow JW, Jones DM, Smith AM, El Kasmi KC, Liu F, Goldsmith MA, Link DC, Murray PJ, et al. Stat3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 2006;108:3682-3690.
7. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R, Haura EB. Stat3 regulates genes common to both wound healing and cancer. Oncogene 2005;24:3397-3408.
8. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C. Stat3 regulates cytokine-mediated generation of inflammatory helper t cells. J Biol Chem 2007;282:9358-9363.
9. Li Y, Du H, Qin Y, Roberts J, Cummings OW, Yan C. Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung. Cancer Res 2007;67:8494-8503.
10. Hokuto I, Ikegami M, Yoshida M, Takeda K, Akira S, Perl AK, Hull WM, Wert SE, Whitsett JA. Stat-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest 2004;113:28-37.
11. Lian X, Qin Y, Hossain SA, Yang L, White A, Xu H, Shipley JM, Li T, Senior RM, Du H, et al. Overexpression of stat3c in pulmonary epithelium protects against hyperoxic lung injury. J Immunol 2005;174:7250-7256.
12. Matsuzaki Y, Xu Y, Ikegami M, Besnard V, Park KS, Hull WM, Wert SE, Whitsett JA. Stat3 is required for cytoprotection of the respiratory epithelium during adenoviral infection. J Immunol 2006;177:527-537.
13. Alonzi T, Fattori E, Cappelletti M, Ciliberto G, Poli V. Impaired stat3 activation following localized inflammatory stimulus in il-6-deficient mice. Cytokine 1998;10:13-18.
14. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (il)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1-20.
15. Jones MR, Quinton LJ, Simms BT, Lupa MM, Kogan MS, Mizgerd JP. Roles of interleukin-6 in activation of stat proteins and recruitment of neutrophils during escherichia coli pneumonia. J Infect Dis 2006;193:360-369.
16. Leemans JC, Vervoordeldonk MJ, Florquin S, van Kessel KP, van der Poll T. Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus. Am J Respir Crit Care Med 2002;165:1445-1450.
17. Rijneveld AW, van den Dobbelsteen GP, Florquin S, Standiford TJ, Speelman P, van Alphen L, van der Poll T. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J Infect Dis 2002;185:123-126.
18. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 1997;176:439-444.
19. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, et al. Role of il-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997;6:315-325.
20. McLoughlin RM, Hurst SM, Nowell MA, Harris DA, Horiuchi S, Morgan LW, Wilkinson TS, Yamamoto N, Topley N, Jones SA. Differential regulation of neutrophil-activating chemokines by il-6 and its soluble receptor isoforms. J Immunol 2004;172:5676-5683.
21. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA. Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 2000;22:535-542.
22. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. Il-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-320.
23. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, Puck JM, Holland SM. Causes of death in hyper-ige syndrome. J Allergy Clin Immunol 2007;119:1234-1240.
24. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, et al. Stat3 mutations in the hyper-ige syndrome. N Engl J Med 2007;357:1608-1619.
25. Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, et al. Dominant-negative mutations in the DNA-binding domain of stat3 cause hyper-ige syndrome. Nature 2007;448:1058-1062.
26. Severgnini M, Takahashi S, Rozo LM, Homer RJ, Kuhn C, Jhung JW, Perides G, Steer M, Hassoun PM, Fanburg BL, et al. Activation of the stat pathway in acute lung injury. Am J Physiol 2004;286:L1282-L1292.
27. Thorley AJ, Ford PA, Giembycz MA, Goldstraw P, Young A, Tetley TD. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type ii epithelial cells and macrophages. J Immunol 2007;178:463-473.
28. Vanderbilt JN, Mager EM, Allen L, Sawa T, Wiener-Kronish J, Gonzalez R, Dobbs LG. Cxc chemokines and their receptors are expressed in type ii cells and upregulated following lung injury. Am J Respir Cell Mol Biol 2003;29:661-668.
29. Perl AK, Wert SE, Nagy A, Lobe CG, Whitsett JA. Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci USA 2002;99:10482-10487.
30. Mizgerd JP, Kubo H, Kutkoski GJ, Bhagwan SD, Scharffetter-Kochanek K, Beaudet AL, Doerschuk CM. Neutrophil emigration in the skin, lungs, and peritoneum: Different requirements for cd11/cd18 revealed by cd18-deficient mice. J Exp Med 1997;186:1357-1364.
31. Quinton LJ, Jones MR, Simms BT, Kogan MS, Robson BE, Skerrett SJ, Mizgerd JP. Functions and regulation of nf-kappab rela during pneumococcal pneumonia. J Immunol 2007;178:1896-1903.
32. Jones MR, Simms BT, Lupa MM, Kogan MS, Mizgerd JP. Lung nfkappab activation and neutrophil recruitment require il-1 and tnf receptor signaling during pneumococcal pneumonia. J Immunol 2005;175:7530-7535.
33. Wikenheiser KA, Vorbroker DK, Rice WR, Clark JC, Bachurski CJ, Oie HK, Whitsett JA. Production of immortalized distal respiratory epithelial cell lines from surfactant protein c/simian virus 40 large tumor antigen transgenic mice. Proc Natl Acad Sci USA 1993;90:11029-11033.
34. Greenberger MJ, Strieter RM, Kunkel SL, Danforth JM, Laichalk LL, McGillicuddy DC, Standiford TJ. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine klebsiella pneumonia. J Infect Dis 1996;173:159-165.
35. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of s100: Proteins s100a8, s100a9, and s100a8/a9 induce neutrophil chemotaxis and adhesion. J Immunol 2003;170:3233-3242.
36. Tsai WC, Strieter RM, Mehrad B, Newstead MW, Zeng X, Standiford TJ. Cxc chemokine receptor cxcr2 is essential for protective innate host response in murine pseudomonas aeruginosa pneumonia. Infect Immun 2000;68:4289-4296.
37. Henke MO, Renner A, Rubin BK, Gyves JI, Lorenz E, Koo JS. Upregulation of s100a8 and s100a9 protein in bronchial epithelial cells by lipopolysaccharide. Exp Lung Res 2006;32:331-347.
38. Boniface K, Diveu C, Morel F, Pedretti N, Froger J, Ravon E, Garcia M, Venereau E, Preisser L, Guignouard E, et al. Oncostatin m secreted by skin infiltrating t lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol 2007;178:4615-4622.
39. Mizgerd JP, Lupa MM, Hjoberg J, Vallone JC, Warren HB, Butler JP, Silverman ES. Roles for early response cytokines during escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for tnf and il-1. Am J Physiol 2004;286:L1302-L1310.
40. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, et al. Targeting stat3 blocks both hif-1 and vegf expression induced by multiple oncogenic growth signaling pathways. Oncogene 2005;24:5552-5560.
41. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, et al. Il-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 2000;106:783-791.
42. Siner JM, Jiang G, Cohen ZI, Shan P, Zhang X, Lee CG, Elias JA, Lee PJ. Vegf-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. FASEB J 2007;21:1422-1432.
43. Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R, Berns A, Jonkers J. Growth inhibition and DNA damage induced by cre recombinase in mammalian cells. Proc Natl Acad Sci USA 2001;98:9209-9214.
44. Sisson TH, Hansen JM, Shah M, Hanson KE, Du M, Ling T, Simon RH, Christensen PJ. Expression of the reverse tetracycline-transactivator gene causes emphysema-like changes in mice. Am J Respir Cell Mol Biol 2006;34:552-560.
45. Levy DE, Darnell JE, Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-662.
46. Battle TE, Frank DA. The role of stats in apoptosis. Curr Mol Med 2002;2:381-392.
47. Yan C, Naltner A, Martin M, Naltner M, Fangman JM, Gurel O. Transcriptional stimulation of the surfactant protein b gene by stat3 in respiratory epithelial cells. J Biol Chem 2002;277:10967-10972.
48. Zhang X, Shan P, Jiang G, Zhang SS, Otterbein LE, Fu XY, Lee PJ. Endothelial stat3 is essential for the protective effects of ho-1 in oxidant-induced lung injury. FASEB J 2006;20:2156-2158.
49. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/jak/stat pathway. Biochem J 1998;334:297-314.
50. Chattopadhyay S, Tracy E, Liang P, Robledo O, Rose-John S, Baumann H. Interleukin-31 and oncostatin-m mediate distinct signaling reactions and response patterns in lung epithelial cells. J Biol Chem 2007;282:3014-3026.
51. Grenier A, Combaux D, Chastre J, Gougerot-Pocidalo MA, Gibert C, Dehoux M, Chollet-Martin S. Oncostatin m production by blood and alveolar neutrophils during acute lung injury. Lab Invest 2001;81:133-141.
52. Ren SG, Seliktar J, Li X, Braunstein GD, Melmed S. Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay. J Clin Endocrinol Metab 1998;83:1275-1283.
53. Wang J, Chen Q, Corne J, Zhu Z, Lee CG, Bhandari V, Homer RJ, Elias JA. Pulmonary expression of leukemia inhibitory factor induces b cell hyperplasia and confers protection in hyperoxia. J Biol Chem 2003;278:31226-31232.
54. Tsan MF, White JE, Wong GH. D-factor and growth hormone enhance tumor necrosis factor-induced increase of mn superoxide dismutase mrna and oxygen tolerance. Cytokine 1992;4:101-105.
55. Ulich TR, Fann MJ, Patterson PH, Williams JH, Samal B, Del Castillo J, Yin S, Guo K, Remick DG. Intratracheal injection of lps and cytokines. V. Lps induces expression of lif and lif inhibits acute inflammation. Am J Physiol 1994;267:L442-L446.
56. Weber MA, Schnyder-Candrian S, Schnyder B, Quesniaux V, Poli V, Stewart CL, Ryffel B. Endogenous leukemia inhibitory factor attenuates endotoxin response. Lab Invest 2005;85:276-284.